Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yinuo Biotech is a leading Chinese synthetic biology company focused on the green manufacturing of high-value chemicals, vitamins, and pharmaceutical intermediates. Founded in 2017, the company leverages a digitalized synthetic biology platform to optimize metabolic pathways and enzyme performance for industrial-scale production. Its primary product portfolio includes Vitamin B12, Biotin, and various amino acids, produced through sustainable fermentation and enzymatic catalysis processes. Yinuo Biotech aims to replace traditional chemical synthesis with bio-based manufacturing to reduce environmental impact and production costs. The company has secured significant venture capital funding to expand its R&D capabilities and manufacturing footprint in the global life sciences and nutrition markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yinuo.